Research and experimental development on natural sciences and engineering
ALGIPHARMA AS
Revenue 2024
NOK 6,000
Operating profit
NOK −6.9m
Equity
NOK 176.1m
Incorporated
1992
Employees
6
Share capital
NOK 2.8m
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 6k | |
| Total operating costs | 6.9m | |
| Operating profit (EBIT) | −6.9m | |
| Net financial items | −2.1m | |
| Profit for the year | −9.0m |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 207.3m | |
| of which current assets | 5.8m | |
| Equity | 176.1m | |
| Total liabilities | 31.2m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.